Recombinant multi-species G6PC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine G6PC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an enzyme belonging to the glucose-6-phosphatase catalytic subunit family. These enzymes are part of a multicomponent integral membrane system that catalyzes the hydrolysis of glucose-6-phosphate, the terminal step in gluconeogenic and glycogenolytic pathways, allowing the release of glucose into the bloodstream. The family member encoded by this gene is found in pancreatic islets and does not exhibit phosphohydrolase activity, but it is a major target of cell-mediated autoimmunity in diabetes. Several alternatively spliced transcript variants of this gene have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
The Alternative Names of target: G-6-Pase 2,G6PC2,G6Pase 2,G6pc-rs,G6pc2,Glucose-6-phosphatase 2,IGRP,Igrp,Islet-specific glucose-6-phosphatase catalytic subunit-related protein

Target products collectionGo to G6PC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0165-Ag-1/ GM-Tg-hg-IP0165-Ag-2 Human G6PC2 protein Human
GM-Tg-rg-IP0165-Ag-1/ GM-Tg-rg-IP0165-Ag-2 Rat G6PC2 protein Rat
GM-Tg-mg-IP0165-Ag-1/ GM-Tg-mg-IP0165-Ag-2 Mouse G6PC2 protein Mouse
GM-Tg-cynog-IP0165-Ag-1/ GM-Tg-cynog-IP0165-Ag-2 Cynomolgus/Rhesus macaque G6PC2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0165-Ag-1/ GM-Tg-felg-IP0165-Ag-2 Feline G6PC2 protein Feline
GM-Tg-cang-IP0165-Ag-1/ GM-Tg-cang-IP0165-Ag-2 Canine G6PC2 protein Canine
GM-Tg-bovg-IP0165-Ag-1/ GM-Tg-bovg-IP0165-Ag-2 Bovine G6PC2 protein Bovine
GM-Tg-equg-IP0165-Ag-1/ GM-Tg-equg-IP0165-Ag-2 Equine G6PC2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0165-Ag-1/ GM-Tg-hg-IP0165-Ag-2; GM-Tg-rg-IP0165-Ag-1/ GM-Tg-rg-IP0165-Ag-2;
GM-Tg-mg-IP0165-Ag-1/ GM-Tg-mg-IP0165-Ag-2; GM-Tg-cynog-IP0165-Ag-1/ GM-Tg-cynog-IP0165-Ag-2;
GM-Tg-felg-IP0165-Ag-1/ GM-Tg-felg-IP0165-Ag-2; GM-Tg-cang-IP0165-Ag-1/ GM-Tg-cang-IP0165-Ag-2;
GM-Tg-bovg-IP0165-Ag-1/ GM-Tg-bovg-IP0165-Ag-2; GM-Tg-equg-IP0165-Ag-1/ GM-Tg-equg-IP0165-Ag-2
Products Name G6PC2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name G6PC2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine G6PC2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.